Objective: To investigate the association of the-174 G/C promoter polymorphism of the interleukin-6 (IL-6) gene with endometriosis in South Indian women.
Methods: The genotype frequencies of the common IL-6174 G/C polymorphism were compared in infertility patients with (n = 232) and without (n = 210) endometriosis using polymerase chain reaction (PCR) and sequencing analysis.
Results: The genotype frequencies among the cases and controls were G/G 62.9% and 71.9%, G/C 34. 1% and 25.2%, and C/C 3.0% and 2.9%. The G and C allele frequencies were 80% and 84.6%, and 20% and 15.4%, respectively. There were no statistically signficant differences in the genotype distributions or allele frequencies between the cases and controls (P = .12).
Conclusions: The present study demonstrates no signficant association between the IL-6 -174 G/C promoter polymorphism and endometriosis in South Indian women.
4. Barlow D, Fernandez-Shaw S. Immune system. In: Shaw RW, ed. Endometriosis: Current understanding and management. Oxford, UK: Blackwell Science, 1995:75-94.
5.
5. Van Snick J. Interleukin-6: An overview. Annu Rev Immunol1990;8:253-278.
6.
6. Jacobs AL, Sehgal PB, Julian J, Carson DD. Secretion and hormonal regulation of interleukin-6 production by mouse uterine stromal and polarized epithelial cells cultured in vitro. Endocrinology1992;131:1037-1046.
7.
7. Tseng JF, Ryan IP, Milam TD, et al. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab1996;81:1118-1122.
8.
8. Akoum A, Lemay A, Paradis I, Rheault N, Maheux R. Secretion of interleukin-6 by human endometriotic cells and regulation by proinflammatory cytokines and sex steroids. Hum Reprod1996;11:2269-2275.
9.
9. Tabibzadeh SS, Santhanam U, Sehgal PB, May LT. Cytokineinduced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 betaJ Immunol1989;142:3134-3139.
10.
10. Rier SE, Zarmakoupis PN, Hu X, Becker JL. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: Correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab1995;80:1431-1437.
11.
11. D'Hooghe TM, Xiao L, Hill JA. Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis. Arch Gynecol Obstet2001;265:40-44.
12.
12. Darai E, Detchev R, Hugol D, Quang NT. Serum and cyst fluid levels of interleukin (IL)-6, IL-8 and tumour necrosis factoralpha in women with endometriomas and benign and malignant cystic ovarian tumours. Hum Reprod2003;18:1681-1685.
13.
13. Khan KN, Masuzaki H, Fujishita A, et al. Association of interleukin-6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis. Acta Obstet Gynecol Scand2002;81:764-771.
14.
14. Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin Chim Acta2004;340:41-56.
15.
15. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Chin Invest1998;102:1369-1376.
16.
16. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem2000;275:18138-18144.
17.
17. Cox ED, Hoffmann SC, DiMercurio BS, et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation2001;72:720-726.
18.
18. DeMichele A, Martin AM, Mick R, et al. Interleukin-6-174G→C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res2003;63:8051-8056.
19.
19. Hefler LA, Grimm C, Ackermann S, et al. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res2003;63:3066-3068.
20.
20. Walch K, Grimm C, Zeillinger R, Huber JC, Nagele F, Hefler LA. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome. Fertil Steril2004;81:1638-1641.
21.
21. Lee MK, Park AJ, Kim DH. Tumor necrosis factor-alpha and interleukin-6 promoter gene polymorphisms are not associated with an increased risk of endometriosisFertil Steril2002;77:1304-1305.
22.
22. Wieser F, Fabjani G, Tempfer C, et al. Analysis of an interleukin-6 gene promoter polymorphism in women with endometriosis by pyrosequencing. J Soc Gynecol Investig2003;10:32-36.
23.
23. Revised American Society for Reproductive Medicine classification of endometriosis. 1996. Fertil Steril1997;67:817-821.
24.
24. Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study?—Design issues for complex genetic traits such as endometriosis. Hum Reprod2002;17:1415-1423.
25.
25. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res1988;16:1215.
26.
26. Schneider S, Roessli D, Excoffier L. Arlequin: A software for population genetics data analysis. Version 2.000. Geneva, Switzerland: University of Geneva, 2000.
27.
27. Olive DL, Schwartz LB. Endometriosis. N Engl J Med1993;328:1759-1769.
28.
28. Halme J. Role of peritoneal inflammation in endometriosisassociated infertility. Ann N Y Acad Sci1991;622:266-274.
29.
29. Witz CA.Interleukin-6: Another piece of the endometriosiscytokine puzzle. Fertil Steril2000;73:212-214.
30.
30. Sharpe-Timms KL, Zimmer RL, Ricke EA, Piva M, Horowitz GM. Endometriotic haptoglobin binds to peritoneal macrophages and alters their functionin women with endometriosis. Fertil Steril2002;78:810-819.
31.
31. Yoshida S, Harada T, Iwabe T, et al. A combination of interleukin-6 and its soluble receptor impairs sperm motility: Implications in infertility associated with endometriosis. Hum Reprod2004;19:1821-1825.
32.
32. Simpson ER. Role of aromatase in sex steroid action. J Mol Endocrinol2000;25:149-156.
33.
33. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: The pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol2002;83:149-155.
34.
34. Bulun SE, Fang Z, Imir G, et al. Aromatase and endometriosis. Semin Reprod Med2004;22:45-50.
35.
35. Iwabe T, Harada T, Sakamoto Y, et al. Gonadotropin releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas. Fertil Steril2003;80:300-304.
36.
36. Bowcock AM, Kidd JR, Lathrop GM, et al. The human “interferon-beta 2/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics1988;3:8-16.
37.
37. Bonafe M, Olivieri F, Cavallone L, et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol2001;31:2357-2361.
38.
38. Dendorfer U. Molecular biology of cytokines. Artif Organs1996;20:437-444.
39.
39. Zawel L, Dai JL, Buckhaults P, et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell1998;1:611-617.
40.
40. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol1995;15:4971-4979.
41.
41. Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: Inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett1997;409:79-85.
42.
42. Kristiansen OP, Nolsoe RL, Larsen L, et al. Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. Hum Mol Genet2003;12:1101-1110.
43.
43. Jones KG, Brull DJ, Brown LC, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation2001;103:2260-2265.
44.
44. Jerrard-Dunne P, Sitzer M, Risley P, et al. Carotid Atherosclerosis Progression Study. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: The Carotid Atherosclerosis Progression Study (CAPS). Stroke2003;34:402-407.
45.
45. Buyalos RP, Funari VA, Azziz R, Watson JM, Martinez-Maza O. Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology. Fertil Steril1992;58:302-306.
46.
46. Mahnke JL, Dawood MY, Huang JC. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril2000;73:166-170.
